Entera Bio LTD DEF 14A proxy statements

Entera Bio Ltd. announced its 2026 Annual Meeting of Shareholders, set for July 14, 2026, to vote on director elections, executive and non-executive director compensation, and amendments to equity plans and articles of association.

Entera Bio Ltd. has announced its upcoming Annual Shareholder Meeting on July 16, 2025, where shareholders will vote on the election of a Class II director, ratification of executive compensation, and the appointment of independent auditors.

Entera Bio Ltd. is seeking shareholder approval for significant executive compensation increases and an updated compensation policy, following a year of substantial shareholder return growth despite a widening net loss.

Entera Bio Ltd. will hold its annual shareholder meeting on July 31, 2024, to vote on director elections, executive compensation, and other corporate matters.

Entera Bio is holding its 2024 Annual Meeting of Shareholders on July 31, 2024, to vote on director elections, executive compensation, an amendment to the 2018 Equity Incentive Plan, and other corporate governance matters.